Sign in Sign up for free

Last updated: 5 September 2024 at 4:09pm EST

Fred Hassan Net Worth




The estimated Net Worth of Fred Hassan is at least $326 Million dollars as of 9 March 2024. Mr. Hassan owns over 106,837 units of AMGEN stock worth over $325,287,354 and over the last 21 years he sold AMGN stock worth over $0. In addition, he makes $343,614 as Independent Director at AMGEN.

Mr. Hassan AMGN stock SEC Form 4 insiders trading

Fred has made over 15 trades of the AMGEN stock since 2010, according to the Form 4 filled with the SEC. Most recently he exercised 106,837 units of AMGN stock worth $35,254,073 on 9 March 2024.

The largest trade he's ever made was buying 570,345 units of AMGEN stock on 14 August 2023 worth over $998,104. On average, Fred trades about 14,587 units every 83 days since 2003. As of 9 March 2024 he still owns at least 985,779 units of AMGEN stock.

You can see the complete history of Mr. Hassan stock trades at the bottom of the page.





Fred Hassan biography

Fred Hassan serves as Independent Director of the Company. Hassan is Director at Warburg Pincus LLC, a global private equity investment institution, since 2018. Mr. Hassan was Special Limited Partner at Warburg Pincus LLC from 2017 to 2018 and Partner and Managing Director from 2011 to 2017 and, prior to that, served as Senior Advisor from 2009 to 2010. Mr. Hassan was Chairman of the Board and Chief Executive Officer of Schering-Plough Corporation from 2003 to 2009. Prior to this, Mr. Hassan was Chairman, President and Chief Executive Officer of Pharmacia Corporation, from 2001 to 2003. Before assuming these roles, he had served as President and Chief Executive Officer of Pharmacia Corporation from its creation in 2000 as a result of the merger of Pharmacia & Upjohn, Inc. with Monsanto Company. He was President and Chief Executive Officer of Pharmacia & Upjohn, Inc. beginning in 1997. Mr. Hassan previously held senior positions with Wyeth (formerly known as American Home Products), including that of Executive Vice President with responsibility for its pharmaceutical and medical products businesses, and served as a member of the board from 1995 to 1997. Prior to that, Mr. Hassan held various roles at Sandoz Pharmaceuticals and headed its U.S. pharmaceuticals businesses. Mr. Hassan has been a director of Intrexon Corporation, a synthetic biology company, since 2016, serving on its Compensation Committee. Mr. Hassan was a director of Time Warner Inc., a media company, from 2009 until its acquisition by AT&T Inc., a provider of communications and digital entertainment services, in 2018. Mr. Hassan was a director of Avon Products, Inc., a manufacturer and marketer of beauty and related products, from 1999 until 2013 and served on its Compensation and Management Development, Nominating and Corporate Governance and Audit Committees, as lead independent director from 2009 to 2012, and Chairman of the Board between January and April 2013. Mr. Hassan was Chairman of the Board of Bausch & Lomb, from 2010 until its a

What is the salary of Fred Hassan?

As the Independent Director of AMGEN, the total compensation of Fred Hassan at AMGEN is $343,614. There are 15 executives at AMGEN getting paid more, with Robert Bradway having the highest compensation of $19,612,800.



How old is Fred Hassan?

Fred Hassan is 74, he's been the Independent Director of AMGEN since 2015. There are no older and 26 younger executives at AMGEN.

What's Fred Hassan's mailing address?

Fred's mailing address filed with the SEC is C/O EYEPOINT PHARMACEUTICALS, INC., 480 PLEASANT STREET, WATERTOWN, MA, 02472.

Insiders trading at AMGEN

Over the last 21 years, insiders at AMGEN have traded over $219,663,137 worth of AMGEN stock and bought 8,904 units worth $919,219 . The most active insiders traders include Robert Eckert, Kevin W Sharer, and Ellen Jamison Kullman. On average, AMGEN executives and independent directors trade stock every 35 days with the average trade being worth of $8,732,261. The most recent stock trade was executed by Nancy A. Grygiel on 3 May 2024, trading 2,117 units of AMGN stock currently worth $662,812.



What does AMGEN do?

Amgen Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. One of the worlds largest independent biotechnology companies, Amgen was established in Thousand Oaks, California, in 1980.



What does AMGEN's logo look like?

AMGEN Inc. logo

Complete history of Mr. Hassan stock trades at AMGEN, Cocrystal Pharma Inc, EyePoint Pharmaceuticals Inc, BridgeBio Pharma Inc, and Precigen Inc

Date
#
Company
 Insider
Trans.
Transaction
 Shares Price per share Total value Shares after Source
9 Mar 2024 PGEN Precigen Inc Fred Hassan
Director
 Option 106,837 $1.75 $186,965
9 Mar 2024
985,779 ↗
14 Aug 2023 PGEN Precigen Inc Fred Hassan
Director
 Buy 570,345 $1.75 $998,104
14 Aug 2023
878,942 ↗
22 Feb 2023 PGEN Precigen Inc Fred Hassan
Director
 Option 61,576 $1.28 $78,817
22 Feb 2023
260,307 ↗
25 Mar 2022 PGEN Precigen Inc Fred Hassan
Director
 Option 16,212 $2.06 $33,397
25 Mar 2022
198,731 ↗
13 Mar 2021 PGEN Precigen Inc Fred Hassan
Director
 Option 62,189 $8.96 $557,213
13 Mar 2021
147,359 ↗
8 Mar 2020 PGEN Precigen Inc Fred Hassan
Director
 Option 24,703 $3.07 $75,838
8 Mar 2020
57,061 ↗
29 Dec 2021 BBIO BridgeBio Pharma Inc Fred Hassan
Buy 19,300 $14.17 $273,481
29 Dec 2021
19,300 ↗
19 Aug 2015 AMGN AMGEN Inc. Fred Hassan
Director
 Buy 3,010 $166.63 $501,556
19 Aug 2015
3,582 ↗


AMGEN executives and stock owners

AMGEN executives and other stock owners filed with the SEC include: